Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of this study is to assess the outcomes and efficacy of ejaculatory preserving TURP in terms of voiding, erectile function, and ejaculation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedResults Posted
Study results publicly available
January 6, 2026
CompletedJanuary 6, 2026
December 1, 2025
1.5 years
June 12, 2023
November 16, 2025
December 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Preservation of Ejaculation
The number of patients who can ejaculate after TURP
6 months
Secondary Outcomes (1)
Maximum Flow Rate (Qmax)
6 months
Study Arms (2)
Group 1
ACTIVE COMPARATORGroup 2
ACTIVE COMPARATORInterventions
Transurethral resection of prostate with preservation of 1cm safety area above verumontanum and without paracollicular digging
Transurethral resection of prostate including whole adenoma till the capsule.
Eligibility Criteria
You may qualify if:
- Adult patient \> 45 years old.
- Drug refractory urinary retention.
- Prostate volume range: 20-60 mL.
- IPSS \> 19 after the medical therapy failure.
- Qmax \< 10 mL/s.
- PSA \< 4 ng/mL.
- Active and healthy sexual life.
You may not qualify if:
- History of prostate or urethral surgery.
- Neurogenic bladder.
- UTI.
- Urethral stricture disease.
- prostate cancer.
- Bleeding diathesis.
- Capsular or bladder perforation during surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, Sohag Governorate, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
* Single center study that may result in different findings than elsewhere. * Small sample size that may produce insignificant results. * Relatively short period of follow-up. * We didn't compare Ejaculatory preserving TURP with other established surgical or minimally invasive techniques such as aquablation and Holmium laser enucleation with ejaculatory sparing modifications.
Results Point of Contact
- Title
- Ahmed Sabri mahmoud
- Organization
- faculty of medicine sohag university
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 12, 2023
First Posted
June 22, 2023
Study Start
July 1, 2023
Primary Completion
January 1, 2025
Study Completion
June 1, 2025
Last Updated
January 6, 2026
Results First Posted
January 6, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share